JP Patent

JP6050813B2 — 二重作用Ｈ１インバースアゴニスト／５−ＨＴ２Ａアンタゴニストとしての（チエノ［２，３−ｂ］［１，５］ベンゾオキサゼピン−４−イル）ピペラジン−１−イル化合物

Assigned to イーライリリーアンドカンパニー · Expires 2016-12-21 · 9y expired

What this patent protects

Patent listed against lumateperone-tosylate.

Drugs covered by this patent

lumateperone-tosylate (LUMATEPERONE TOSYLATE)

Patent Metadata

Patent number: JP6050813B2
Jurisdiction: JP
Classification: —
Expires: 2016-12-21
Drug substance claim: No
Drug product claim: No
Assignee: イーライリリーアンドカンパニー
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.